Back to search

Article

Harnessing Plant Chloroplasts for Oral Delivery of a Multi-epitope HPV Vaccine: Toward Cost-Effective Systemic and Mucosal Immunization

2025-11-22

Abstract excerpt

<title>Abstract</title> <p> Human papillomavirus (HPV) is a major causative agent of cervical and other mucosal cancers, yet the distribution and accessibility of current prophylactic vaccines remain limited, especially in low- and middle-income countries (LMICs), due to high production costs, cold-chain dependency, and limited induction of mucosal immunity. To overcome these challenges, we designed a multi-epit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9f10d6ac-9d81-5144-9673-ff6876e09b09
DOI
10.21203/rs.3.rs-7801011/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Harnessing Plant Chloroplasts for Oral Delivery of a Multi-epitope HPV Vaccine: Toward Cost-Effective Systemic and Mucosal ImmunizationDOI 10.21203/rs.3.rs-7801011/v1
Plastid expression of a double-pentameric vaccine candidate containing human papillomavirus-16 L1 antigen fused with LTB as adjuvant: transplastomic plants show pleiotropic phenotypes.Semantic proximity
Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization.Semantic proximity
Translational fusion and redirection to thylakoid lumen as strategies to enhance accumulation of human papillomavirus E7 antigen in tobacco chloroplasts.Semantic proximity
Plant-Based Virus-Like Particle (VLP) Vaccines Against Influenza and Hepatitis VirusesSemantic proximity
Potential of Recombinant Chimeric HPV16 L1/L2 VLPs Produced by Distinct Cell Lineages Such as Prophylactic Nanovaccine and Therapeutic Drug NanocarriersSemantic proximity
Transplastomic Biofactory for the Production of Functional Human α-Lactalbumin for Nutritional and Therapeutic ApplicationsSemantic proximity
Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines.Semantic proximity
N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitroSemantic proximity
Efficient production of chimeric Human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plantsSemantic proximity
In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccineSemantic proximity
Identification of Immunodominant T-lymphocyte Epitope Peptides in HPV 1, 2 and 3 L1 Protein for Novel Cutaneous Wart VaccineSemantic proximity
Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today?Semantic proximity
Select a neighboring publication to make it the new centre.